SECUADO 3.8 MG/Day 24HR Transdermal System

RxCUI: 2265729
RxNorm name: SECUADO 3.8 MG/Day 24HR Transdermal System
Display name: SECUADO 3.8 MG/Day 24HR Transdermal System
Full name: SECUADO 3.8 MG/Day 24HR Transdermal System
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SECUADO	ASENAPINE	Noven Therapeutics, LLC	685eaf44-5944-4f38-afba-0a4fc0b3462b	2025-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2265729

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
685eaf44-5944-4f38-afba-0a4fc0b3462b	SECUADO 3.8 MG/Day 24HR Transdermal System	PSN	13	These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009	20250130
685eaf44-5944-4f38-afba-0a4fc0b3462b	Secuado 3.8 MG/Day 24 HR Transdermal System	SY	13	These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009	20250130
685eaf44-5944-4f38-afba-0a4fc0b3462b	24 HR Secuado 0.158 MG/HR Transdermal System	SY	13	These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009	20250130
685eaf44-5944-4f38-afba-0a4fc0b3462b	24 HR asenapine 0.158 MG/HR Transdermal System [Secuado]	SBD	13	These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009	20250130